Novonesis AS

Director's Dealing • Feb 12, 2014

February 12, 2014

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name	Novo A/S
Relation/category of close relation	Novo A/S is closely related to the chairman of
	Novozymes' board of directors, Henrik Gürtler
Trading date	February 10, 2014
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Sale of shares
Volume of transaction buy(+)/ sell (-)	-100,865
Value of transaction (DKK)	23,972,776.19 DKK

Name	Novo A/S
Relation/category of close relation	Novo A/S is closely related to the chairman of
	Novozymes' board of directors, Henrik Gürtler
Trading date	February 11, 2014
Market	Nasdaq OMX Copenhagen A/S
Character of transaction	Sale of shares
Volume of transaction buy(+)/ sell (-)	-58,720
Value of transaction (DKK)	14,034,884.46 DKK

This sale has been completed according to earlier communicated intention by Novo A/S to keep its relative holding of Novozymes B shares at the level it held prior to Novozymes' cancellation of B shares on 5 April 2013 (Company announcement no. 50, August, 2011).

Contact information

Investor Relations:
Thomas Bomhoff (DK)	+45 3077 1226	tsbm@novozymes.com
Klaus Sindahl (DK)	+45 5363 0134	ksdh@novozymes.com
Martin Riise (USA)	+1 919 649 2565	mrsn@novozymes.com

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Email: novozymesIR@novozymes.com Internet: www.novozymes.com